OpenAlex
PricingAboutJobs
Log inGet started
Work

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

HTML

Year: 2011
Type: article
Source: Diabetes and Vascular Disease Research
DOI: 10.1177/1479164111408937
Authors: Steven P Marso, Jason B Lindsey, Joshua M Stolker, John A House, Gabriela Martinez Ravn, Kevin F Kennedy, Troels M Jensen, John B Buse
Institutions: Saint Luke's Health System, Saint Luke's Hospital, Saint Louis University, Novo Nordisk (Denmark), University of North Carolina at Chapel Hill
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: liraglutide, cardiovascular safety, major adverse cardiovascular events, GLP-1 receptor agonists, type 2 diabetes, myocardial infarction, stroke, cardiovascular mortality, serious adverse events, pooled analysis
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Medicines Company, Novo Nordisk
OpenAlex ID: W2140682563
FWCI: 12.53
Cites: 14
Cited by: 105
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security